276 related articles for article (PubMed ID: 36219531)
1. COVID-19 and neurodegeneration: The mitochondrial connection.
Denaro CA; Haloush YI; Hsiao SY; Orgera JJ; Osorio T; Riggs LM; Sassaman JW; Williams SA; Monte Carlo AR; Da Costa RT; Grigoriev A; Solesio ME
Aging Cell; 2022 Nov; 21(11):e13727. PubMed ID: 36219531
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanisms of SARS-CoV-2/COVID-19 Pathogenicity on the Central Nervous System: Bridging Experimental Probes to Clinical Evidence and Therapeutic Interventions.
Groppa SA; Ciolac D; Duarte C; Garcia C; Gasnaș D; Leahu P; Efremova D; Gasnaș A; Bălănuță T; Mîrzac D; Movila A
Adv Exp Med Biol; 2022; 1376():1-27. PubMed ID: 34735712
[TBL] [Abstract][Full Text] [Related]
3. Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19.
Stefano GB; Büttiker P; Weissenberger S; Ptacek R; Wang F; Esch T; Bilfinger TV; Raboch J; Kream RM
Curr Neuropharmacol; 2022; 20(6):1229-1240. PubMed ID: 34951387
[TBL] [Abstract][Full Text] [Related]
4. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
Murta V; Villarreal A; Ramos AJ
ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and neurodegenerative diseases.
Fu YW; Xu HS; Liu SJ
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4535-4544. PubMed ID: 35776055
[TBL] [Abstract][Full Text] [Related]
6. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
Burks SM; Rosas-Hernandez H; Alejandro Ramirez-Lee M; Cuevas E; Talpos JC
Brain Behav Immun; 2021 Jul; 95():7-14. PubMed ID: 33412255
[TBL] [Abstract][Full Text] [Related]
7. Role of aging in Blood-Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19.
Adesse D; Gladulich L; Alvarez-Rosa L; Siqueira M; Marcos AC; Heider M; Motta CS; Torices S; Toborek M; Stipursky J
Fluids Barriers CNS; 2022 Aug; 19(1):63. PubMed ID: 35982454
[TBL] [Abstract][Full Text] [Related]
8. COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration?
Onaolapo A; Onaolapo O
CNS Neurol Disord Drug Targets; 2022; 21(9):818-829. PubMed ID: 34951374
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Infection to Premature Neuronal Aging and Neurodegenerative Diseases: Is there any Connection with Hypoxia?
Sivagurunathan N; Calivarathan L
CNS Neurol Disord Drug Targets; 2024; 23(4):431-448. PubMed ID: 37073650
[TBL] [Abstract][Full Text] [Related]
11. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.
Alam SB; Willows S; Kulka M; Sandhu JK
Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062
[TBL] [Abstract][Full Text] [Related]
12. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS.
Szabo MP; Iba M; Nath A; Masliah E; Kim C
Exp Mol Med; 2022 Apr; 54(4):447-454. PubMed ID: 35396576
[TBL] [Abstract][Full Text] [Related]
13. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
Baig AM
ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
[TBL] [Abstract][Full Text] [Related]
14. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
15. The Potential Role of COVID-19 in the Pathogenesis of Multiple Sclerosis-A Preliminary Report.
Satheesh NJ; Salloum-Asfar S; Abdulla SA
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696521
[TBL] [Abstract][Full Text] [Related]
16. Does SARS-CoV-2 infection cause chronic neurological complications?
Hascup ER; Hascup KN
Geroscience; 2020 Aug; 42(4):1083-1087. PubMed ID: 32451846
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S
J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 and neurodegenerative diseases: what we know and what we don't.
Lingor P; Demleitner AF; Wolff AW; Feneberg E
J Neural Transm (Vienna); 2022 Sep; 129(9):1155-1167. PubMed ID: 35434769
[TBL] [Abstract][Full Text] [Related]
19. Inorganic Polyphosphate, Mitochondria, and Neurodegeneration.
Urquiza P; Solesio ME
Prog Mol Subcell Biol; 2022; 61():27-49. PubMed ID: 35697936
[TBL] [Abstract][Full Text] [Related]
20. Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis.
Stefano GB; Büttiker P; Weissenberger S; Martin A; Ptacek R; Kream RM
Med Sci Monit; 2021 May; 27():e933015. PubMed ID: 34016942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
